Understanding Non-small cell lung cancer patient Characteristics, treatment patterns and Outcomes

Trial Identifier:	D9260R00023
Sponsor:	AstraZeneca
Start Date:	October 2025
Primary Completion Date:	December 2025
Study Completion Date:	December 2025
Condition:	Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
India	New Delhi, India

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.